← Back to Search

Cognitive Remediation

Cognitive Remediation Therapy for Schizophrenia (RC2S Trial)

N/A
Recruiting
Research Sponsored by Douglas Mental Health University Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
DSM-5 diagnosis of schizophrenia or a related psychotic disorder
Being 18 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the administration time is estimated at 30 minutes.
Awards & highlights

RC2S Trial Summary

This trial will investigate whether a cognitive remediation program can be administered remotely to people with schizophrenia and related disorders.

Who is the study for?
This trial is for adults with schizophrenia or related psychotic disorders who are stable and treated at the Douglas Mental Health University Hospital. They must have trouble with social cognition, access to digital technology and a private space, and be able to nominate an emergency contact. People can't join if they're hospitalized, don't speak French or English, have cognitive issues due to organic causes like brain trauma, or have mental retardation or autism.Check my eligibility
What is being tested?
The study tests the RC2S+ program's remote delivery for improving social cognition in people with schizophrenia-related conditions. It aims to see if this online cognitive remediation approach is practical and acceptable for participants.See study design
What are the potential side effects?
Since this intervention involves a non-medical treatment focusing on cognitive exercises delivered remotely, typical drug side effects are not expected. However, participants may experience fatigue or frustration during the tasks.

RC2S Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with schizophrenia or a similar mental health condition.
Select...
I am 18 years old or older.

RC2S Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the administration time is estimated at 30 minutes.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the administration time is estimated at 30 minutes. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Combined Stories Test (COST)
Interpersonal, Personal and Situational Attributions Questionnaire (IPSAQ)
Penn Emotion Recognition Task (ER-40)
+1 more
Secondary outcome measures
DACOBS: Davos Assessment of Cognitive Biases Scale
First-episode social functioning scale (FESF)
PANSS-6: Positive and Negative Syndrome Scale
+3 more
Other outcome measures
Goal Attainment Scale (GAS)
MUSIC® Model of Motivation Inventory, Cognitive Training version (MMI-CT)
NIMH suicide screening questionnaire (NIMH-SSQ)
+4 more

RC2S Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Intervention with RC2S+ that consists of 24 biweekly sessions

Find a Location

Who is running the clinical trial?

Douglas Mental Health University InstituteLead Sponsor
29 Previous Clinical Trials
2,700 Total Patients Enrolled
3 Trials studying Schizophrenia
573 Patients Enrolled for Schizophrenia
McGill UniversityLead Sponsor
392 Previous Clinical Trials
984,481 Total Patients Enrolled
2 Trials studying Schizophrenia
439 Patients Enrolled for Schizophrenia

Media Library

Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+) (Cognitive Remediation) Clinical Trial Eligibility Overview. Trial Name: NCT05017532 — N/A
Schizophrenia Research Study Groups: Intervention
Schizophrenia Clinical Trial 2023: Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+) Highlights & Side Effects. Trial Name: NCT05017532 — N/A
Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+) (Cognitive Remediation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05017532 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently recruiting participants?

"Clinicaltrials.gov indicates that this clinical trial is actively looking for volunteers, with the research campaign first being posted on June 1st 2022 and most recently revised on October 21st 2022."

Answered by AI

What do researchers hope to learn by conducting this trial?

"The principal aim of this trial is to assess the effectiveness of Penn Emotion Recognition Task (ER-40) over a predetermined period. In addition, Patient Health Questionnaire (PHQ-9), Davos Assessment of Cognitive Biases Scale (DACOBS), and Positive and Negative Syndrome Scale (PANSS-6) will be used as secondary measures for evaluation; each requiring approximately 5 minutes in administration. PHQ-9 evaluates major depression criteria, DACOBS gauges cognitive biases via Likert scale responses from 1 - 7, while PANSS-6 examines schizophrenic symptoms such as delusions, hallucinations, flat"

Answered by AI

How many individuals are engaged in this clinical research?

"Affirmative. Clinicaltrials.gov supports the assertion that this clinical trial is actively recruiting participants, beginning on January 6th 2022 and with its most recent update occurring on October 21st of the same year. The study seeks to recruit 26 individuals from a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
What site did they apply to?
Douglas Mental Health University Institute
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~3 spots leftby Aug 2024